225 related articles for article (PubMed ID: 24318733)
1. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
2. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y receptor interactions regulate its mitogenic activity.
Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C; Mahajan A; Hong SH; Galli S; Zhu S; Tilan JU; Abualsaud N; Adnani M; Chung S; Elmansy N; Rodgers J; Rodriguez O; Albanese C; Wang H; Regan M; Zgonc V; Blancato J; Krawczyk E; Gallicano GI; Girgis M; Cheema A; Iżycka-Świeszewska E; Cavalli LR; Pack SD; Kitlinska J
Nat Commun; 2022 Apr; 13(1):2323. PubMed ID: 35484119
[TBL] [Abstract][Full Text] [Related]
8. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy.
Lu C; Tilan JU; Everhart L; Czarnecka M; Soldin SJ; Mendu DR; Jeha D; Hanafy J; Lee CK; Sun J; Izycka-Swieszewska E; Toretsky JA; Kitlinska J
J Biol Chem; 2011 Aug; 286(31):27494-505. PubMed ID: 21680731
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.
Sánchez ML; Rodríguez FD; Coveñas R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373115
[TBL] [Abstract][Full Text] [Related]
12. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
[TBL] [Abstract][Full Text] [Related]
13. Activation of NPY type 5 receptors induces a long-lasting increase in spontaneous GABA release from cerebellar inhibitory interneurons.
Dubois CJ; Ramamoorthy P; Whim MD; Liu SJ
J Neurophysiol; 2012 Mar; 107(6):1655-65. PubMed ID: 22190627
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y modulates excitatory synaptic transmission and promotes social behavior in the mouse nucleus accumbens.
Smith NK; Kondev V; Hunt TR; Grueter BA
Neuropharmacology; 2022 Oct; 217():109201. PubMed ID: 35917875
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
17. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
18. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice.
Lee EW; Grant DS; Movafagh S; Zukowska Z
Peptides; 2003 Jan; 24(1):99-106. PubMed ID: 12576090
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
20. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]